0001354457-23-001001.txt : 20231227
0001354457-23-001001.hdr.sgml : 20231227
20231227090253
ACCESSION NUMBER: 0001354457-23-001001
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20231227
DATE AS OF CHANGE: 20231227
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Brickell Biotech, Inc.
DATE OF NAME CHANGE: 20190830
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
ORGANIZATION NAME:
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0000819050
Fresh Tracks Therapeutics, Inc.
000-21088
9373 Towne Centre Drive, Suite 100
San Diego
CA
CALIFORNIA
92121
1 858 646-1100
Common stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-12-27
EX-99.25
2
frtxdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, December 27, 2023,
Fresh Tracks Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Fresh Tracks Therapeutics, Inc., effective
at the opening of the trading session on January 8, 2024.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), 5550(a)(2),
5605(b)(1), 5605(c)(2), and 5605(d)(2). The Company was notified of
the Staff determination on October 10, 2023. On October 17, 2023,
the Company exercised its right to appeal the Staff determination
to the Listing Qualifications Hearings Panel (Panel) pursuant to
Rule 5815. A hearing on the matter was scheduled for December 21,
2023. On December 15, 2023, the Company witdrew its appeal. The Company
securities were suspended on December 19, 2023. The Staff determination
to delist the Company securities became final on December 19, 2023.